Winter 2025
By Cyrena Musset
The Cure Alzheimer’s Fund awarded $201,250 to Peter Sicinski, MD, PhD, to advance his research on anticancer compounds that may reverse Alzheimer’s symptoms. His work focuses on preclinical validation, investigating their potential to restore memory and synaptic health, and uncovering molecular mechanisms—offering hope for transformative Alzheimer’s treatments.